Treatment of endotoxemia
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Veterinary Clinics of North America: Equine Practice
- Vol. 19 (3) , 681-695
- https://doi.org/10.1016/j.cveq.2003.08.006
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular FailureHypertension, 2002
- Lipopolysaccharide EndotoxinsAnnual Review of Biochemistry, 2002
- Cyclooxygenase inhibitors: any reservations?Internal Medicine Journal, 2001
- Endotoxin, interleukin-6 and tumor necrosis factor concentrations in equine acute abdominal disease: relation to clinical outcomeInnate Immunity, 1995
- Kinetics, dose response, tachyphylaxis and cross‐tachyphylaxis of vascular leakage induced by endotoxin, zymosan‐activated plasma and platelet‐activating factor in the horseJournal of Veterinary Pharmacology and Therapeutics, 1995
- Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophaegeal varices, and hyperdynamic circulation.Published by Elsevier ,1995
- Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemiaEquine Veterinary Journal, 1993
- Antagonism of endotoxin‐induced disruption of equine gastrointestinal motility with the platelet‐activating factor antagonist WEB 2086Journal of Veterinary Pharmacology and Therapeutics, 1990
- Therapy of Suspected Septicemia in Neonatal Foals Using Plasma‐containing Antibodies to Core Lipopolysaccharide (LPS)Journal of Veterinary Internal Medicine, 1987
- Low dose flunixin meglumine: Effects on eicosanoid production and clinical signs induced by experimental endotoxaemia in horsesEquine Veterinary Journal, 1987